CN101695584A - Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof - Google Patents
Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof Download PDFInfo
- Publication number
- CN101695584A CN101695584A CN200910152789A CN200910152789A CN101695584A CN 101695584 A CN101695584 A CN 101695584A CN 200910152789 A CN200910152789 A CN 200910152789A CN 200910152789 A CN200910152789 A CN 200910152789A CN 101695584 A CN101695584 A CN 101695584A
- Authority
- CN
- China
- Prior art keywords
- composite material
- doped
- synergistically
- calcium phosphate
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明公开的促骨再生修复的可注射复合材料是由海藻酸钠、壳聚糖、多元微量元素协同掺杂磷酸钙多孔微球、生物活性玻璃纳米颗粒为组元经去离子水和细胞培养液调制复合制备而成,其组分的质量百分数含量为:海藻酸钠0.10~0.50%;壳聚糖0.01~0.20%;多元微量元素协同掺杂磷酸钙多孔微球5~30%;生物活性玻璃0.05~0.50%;细胞培养液25~55%;去离子水30~45%。本发明制备工艺简单,制得的复合材料具有优良的可注射性和快速降解特性,水凝胶网络能富集由无机微粒降解释放的钙、磷离子和微量元素,能促进成骨性细胞迁移、生长、增殖和分化,对骨内微损伤、骨折或骨缺损具有快速诱导骨再生并促进骨修复的功效。The injectable composite material for promoting bone regeneration and repair disclosed by the present invention is composed of sodium alginate, chitosan, multivariate trace elements synergistically doped with calcium phosphate porous microspheres, and bioactive glass nanoparticles as components through deionized water and cell culture. It is prepared by compounding and compounding liquid, and the mass percentage content of its components is: sodium alginate 0.10-0.50%; chitosan 0.01-0.20%; multivariate trace elements synergistically doped calcium phosphate porous microspheres 5-30%; biological activity Glass 0.05-0.50%; cell culture medium 25-55%; deionized water 30-45%. The preparation process of the invention is simple, and the prepared composite material has excellent injectability and rapid degradation characteristics, and the hydrogel network can enrich the calcium, phosphorus ions and trace elements released by the degradation of inorganic particles, and can promote the migration of osteoblast cells , growth, proliferation and differentiation, and has the effect of rapidly inducing bone regeneration and promoting bone repair for intraosseous micro-injury, fracture or bone defect.
Description
技术领域 technical field
本发明涉及一种水凝胶-生物活性无机微粒可注射复合物骨修复材料、制备方法及用途,属于生物医用材料和再生医学技术领域。The invention relates to a hydrogel-bioactive inorganic microparticle injectable composite bone repair material, a preparation method and application, and belongs to the technical fields of biomedical materials and regenerative medicine.
背景技术 Background technique
随着日益严峻的人口膨胀和老龄化时代的来临,骨质疏松症引发的骨损伤治疗成为各个国家的重要议题。骨质疏松的基本特征是骨密度下降和骨脆性显著提高,脊柱、股骨、腕骨等部位骨内微损伤、骨折以及大面积骨缺损的风险性大大增加。With the increasingly severe population expansion and the advent of the aging era, the treatment of bone damage caused by osteoporosis has become an important issue in various countries. The basic characteristics of osteoporosis are decreased bone density and significantly increased bone fragility, and the risk of intraosseous micro-injuries, fractures, and large-scale bone defects in the spine, femur, and wrist is greatly increased.
目前,国内外尚无特别有效的骨质疏松症治疗药物,主要以预防为主。长期以来,骨质疏松性骨折和骨缺损的治疗以金属或合金材料内固定、关节置换等为主,不宜置换术的病人采用牵引复位等保守治疗。但是,骨折延迟愈合或者骨不连、内固定失败等常见问题造成患者长期卧床,并导致大量并发症,因而其致残率和死亡率一直居高不下。At present, there are no particularly effective drugs for the treatment of osteoporosis at home and abroad, and the main focus is on prevention. For a long time, the treatment of osteoporotic fractures and bone defects has been mainly based on internal fixation with metal or alloy materials, joint replacement, etc. Patients who are not suitable for replacement surgery are treated conservatively such as traction reduction. However, common problems such as delayed fracture union or nonunion and failure of internal fixation cause patients to stay in bed for a long time and lead to a large number of complications, so their disability and mortality rates have remained high.
近几年来,微创内固定手术因其创口小、减少失血等优点在临床上逐渐受到重视,但是内固定材料的生物活性设计仍停留在内固定与置换金属类材料表面改性,促进骨折断裂面愈合的效果并不明显。因此,加快研制能促进骨折愈合的新材料和探索骨质疏松性骨折、骨缺损治疗的新模式,缩短治疗时间,避免并发症的发生,是降低死亡率并彻底治愈骨质疏松骨折的有效途径。In recent years, minimally invasive internal fixation surgery has gradually received clinical attention due to its advantages of small wounds and reduced blood loss. However, the bioactive design of internal fixation materials is still limited to surface modification of internal fixation and replacement metal materials to promote fracture fracture. The effect of surface healing is not obvious. Therefore, accelerating the development of new materials that can promote fracture healing and exploring new models of treatment for osteoporotic fractures and bone defects, shortening treatment time, and avoiding complications are effective ways to reduce mortality and completely cure osteoporotic fractures .
促进骨质疏松性骨折愈合和缺损修复对生物材料的物理化学和生物学特性提出了非常高的要求,一方面,要求植入材料具有快速的降解性,以满足新生骨张入;另一方面,要求材料具有优越的生物活性,能快速诱导骨再生,促进骨折断面骨愈合;此外,对植入材料递送到骨折断裂面和缺损处的技术要求较高,要求材料具有高度流变性,能通过注射等途径让材料进入缺损内任意狭小空缺部位,形成均匀充填。目前,骨缺损填充修复用常规材料的生物活性差,以致密性微纳米颗粒构筑的材料还存在骨再生与材料降解速率难匹配,磷酸钙自固化材料注入骨折断面后引起血栓等问题,因此目前临床上单纯的磷酸钙陶瓷和自固化材料、生物玻璃大颗粒填充材料等均无法满足骨质疏松性骨折和缺损修复治疗的要求。The promotion of osteoporotic fracture healing and defect repair puts forward very high requirements on the physicochemical and biological properties of biomaterials. On the one hand, the implant materials are required to have rapid degradability to meet the needs of new bone expansion; , it is required that the material has superior biological activity, can quickly induce bone regeneration, and promote bone healing at the fracture site; in addition, the technical requirements for delivering the implant material to the fracture surface and defect are relatively high, and the material is required to be highly rheological and able to pass through Injection and other methods allow the material to enter any narrow vacancy in the defect to form a uniform filling. At present, the bioactivity of conventional materials for bone defect filling and repair is poor, and the materials constructed with dense micro-nano particles still have problems such as bone regeneration and material degradation rates that are difficult to match, and calcium phosphate self-curing materials are injected into fractures and cause thrombosis. Clinically, pure calcium phosphate ceramics, self-curing materials, and bioglass large particle filling materials cannot meet the requirements of osteoporotic fracture and defect repair.
多孔磷酸八钙(Ca8(HPO4)2(PO4)4·5H2O)是近几年来逐渐受到广泛重视的一种介稳型磷酸钙盐,研究显示,这种磷酸钙盐是人体骨齿组织磷灰石的前驱体物质,在生理环境中降解性比磷酸三钙和羟基磷灰石都更为优良。最近几年来的大量动物模型和体外实验研究结果显示,磷酸八钙植入材料不仅比磷酸三钙和羟基磷灰石具有更为优越的生物可降解性和生物活性(O.Suzuki,et al.Curr.Med.Chem.2008,15,305-313),并具有促进骨髓间充质干细胞向成骨细胞分化的诱导活性潜力(P.Habibovic,et al.J Mater Sci Mater Med.2004 15,373-80;T.Anada,et al.Tissue Eng.Part A.2008,Jun,965-978.)。在磷酸八钙中掺入硅、锶、锌、镁等微量元素后可望能改善材料的生物活性、生物降解性和骨缺损修复效果,它们在调节骨骼代谢、增进骨强度中发挥不可替代的生物功效。Porous octacalcium phosphate (Ca 8 (HPO 4 ) 2 (PO 4 ) 4 ·5H 2 O) is a metastable calcium phosphate salt that has gradually received widespread attention in recent years. Studies have shown that this calcium phosphate salt is The precursor material of bone and tooth tissue apatite has better degradability in physiological environment than tricalcium phosphate and hydroxyapatite. A large number of animal models and in vitro experimental studies in recent years have shown that octacalcium phosphate implant materials not only have superior biodegradability and biological activity than tricalcium phosphate and hydroxyapatite (O.Suzuki, et al. Curr.Med.Chem.2008, 15, 305-313), and has the potential to induce activity of promoting bone marrow mesenchymal stem cells to differentiate into osteoblasts (P.Habibovic, et al.J Mater Sci Mater Med.2004 15, 373 -80; T. Anada, et al. Tissue Eng. Part A. 2008, Jun, 965-978.). Doping silicon, strontium, zinc, magnesium and other trace elements in octacalcium phosphate is expected to improve the bioactivity, biodegradability and bone defect repair effect of the material. They play an irreplaceable role in regulating bone metabolism and enhancing bone strength. Biological efficacy.
海藻酸钠是一种带负电荷密度很高的水溶性聚电解质多糖,具有良好的降解性和生物相容性,已被大量用于组织工程支架和药物包埋材料。壳聚糖是一种天然的聚阳离子多糖,易降解且产物无毒性,其降解又可为细胞及组织的长入提供空间,从而可以促进新骨的生成。这两种物质调和形成的高含水率水凝胶具有优越的流变性和结构稳定性。Sodium alginate is a water-soluble polyelectrolyte polysaccharide with high negative charge density, which has good degradability and biocompatibility, and has been widely used in tissue engineering scaffolds and drug embedding materials. Chitosan is a natural polycationic polysaccharide, which is easy to degrade and the product is non-toxic. Its degradation can provide space for the growth of cells and tissues, thereby promoting the formation of new bone. The high water content hydrogel formed by the reconciliation of these two substances has excellent rheology and structural stability.
根据现有临床应用文献报道和生物材料研究进展的最新知识来看,迫切需要探索由高生物活性组元与类似细胞外基质的复合材料系统,研制在化学组成和生物学性能上均能满足临床上骨质疏松患者人体骨内微损伤、骨折以及大面积骨缺损快速愈合、完全修复更为理想的活性材料,这样的材料具备类似骨组织的高孔率凝胶态细胞外基质和无机矿物的化学成分,尤其是多种微量元素的复合,从而具备在细胞及分子水平上实现对成骨相关(干)细胞增殖和分化的主动调控,激活与骨再生相关的基因快速表达,实现在宿主分子、细胞和组织上接受摄取或植入提供的活性物质准确调控和应答,并且多种微量元素能协同调控材料降解性,以达到骨缺损再生修复协同匹配的最佳效果。According to the current clinical application literature reports and the latest knowledge on the research progress of biomaterials, it is urgent to explore composite material systems composed of highly bioactive components and similar extracellular matrix, and to develop composite materials that can meet clinical requirements in terms of chemical composition and biological properties. It is a more ideal active material for rapid healing and complete repair of micro-injuries, fractures, and large-area bone defects in patients with osteoporosis. Such materials have a high-porosity gel-state extracellular matrix similar to bone tissue and inorganic minerals. Chemical components, especially the compounding of various trace elements, can actively regulate the proliferation and differentiation of osteoblast-related (stem) cells at the cellular and molecular levels, activate the rapid expression of genes related to bone regeneration, and achieve , Cells and tissues accept the active substances provided by ingestion or implantation to accurately regulate and respond, and a variety of trace elements can synergistically regulate the degradability of materials to achieve the best synergistic matching effect of bone defect regeneration and repair.
发明内容 Contents of the invention
本发明的目的是提供一种具有细胞外基质凝胶多孔网络微结构、并含多种微量元素明显促进骨质疏松性骨折快速愈合和骨缺损再生修复的微创治疗型可注射复合材料及其制备方法。The object of the present invention is to provide a minimally invasive therapeutic injectable composite material which has a microstructure of extracellular matrix gel porous network and contains a variety of trace elements to significantly promote the rapid healing of osteoporotic fractures and the regeneration and repair of bone defects and its Preparation.
本发明的促骨再生修复的可注射复合材料,是由海藻酸钠、壳聚糖、多元微量元素协同掺杂磷酸钙多孔微球、生物活性玻璃纳米颗粒为组元经去离子水和细胞培养液调制复合制备而成,其组分的质量百分数含量为:The injectable composite material for promoting bone regeneration and repair of the present invention is composed of sodium alginate, chitosan, multivariate trace elements synergistically doped with calcium phosphate porous microspheres, and bioactive glass nanoparticles as components through deionized water and cell culture. It is prepared by compounding liquid modulation, and the mass percentage of its components is:
海藻酸钠 0.10~0.50%;Sodium alginate 0.10~0.50%;
壳聚糖 0.01~0.20%;Chitosan 0.01~0.20%;
多元微量元素协同掺杂磷酸钙多孔微球 5~30%;Multivariate trace elements synergistically doped calcium phosphate porous microspheres 5-30%;
生物活性玻璃 0.05~0.50%;Bioactive glass 0.05~0.50%;
细胞培养液 25~55%;Cell culture fluid 25-55%;
去离子水 30~45%,上述组分之和为100%。Deionized water 30-45%, the sum of the above components is 100%.
上述的多元微量元素协同掺杂磷酸钙是锌、锶、镁和硅至少两种协同掺杂的磷酸八钙、羟基磷灰石或者两者的复合物,磷酸钙多孔微球以氧化物形式表示的质量百分数含量为:The aforementioned calcium phosphate synergistically doped with multivariate trace elements is at least two synergistically doped octacalcium phosphate, hydroxyapatite, or a composite of the two of zinc, strontium, magnesium, and silicon, and the calcium phosphate porous microspheres are expressed in the form of oxides The mass percentage content of is:
CaO 40~55%
P2O5 38~44%P 2 O 5 38~44%
SiO2 0~0.3%
SrO 0~5.5%
ZnO 0~3.5%
MgO 0~4.5%
H2O 3~8%,上述组分之和为100%,且SiO2、ZnO、MgO和SrO至少两种物质不同时为0。H 2 O 3-8%, the sum of the above components is 100%, and at least two substances of SiO 2 , ZnO, MgO and SrO are not 0 at the same time.
上述的生物活性玻璃以氧化物形式表示的摩尔百分数含量为:The mole percentage content of the above-mentioned bioactive glass expressed in the form of oxide is:
CaO 32~50%CaO 32~50%
P2O5 0~12%P 2 O 5 0~12%
SiO2 40~56%
B2O3 0~12%B 2 O 3 0~12%
Na2O 3~8% Na2O 3~8%
所说的多元微量元素协同掺杂磷酸钙多孔微球的粒径为5~600μm;所说的生物活性玻璃颗粒粒径为50~800nm。The particle size of the multi-component trace elements synergistically doped calcium phosphate porous microspheres is 5-600 μm; the particle size of the bioactive glass particles is 50-800 nm.
本发明的促骨再生修复的可注射复合材料的制备方法,包括以下步骤:The preparation method of the injectable composite material for promoting bone regeneration repair of the present invention comprises the following steps:
1)将含SiO3 2-、PO4 3-的无机盐按摩尔比1∶10加入聚天冬氨酸钠或聚丙稀酸钠水溶液中,控制磷酸钠浓度为1~10%,将此磷酸钠混合溶液维持在37~60℃,并调节混合溶液的pH值为4.8~7.0,,再将含Ca2+、Sr2+、Zn2+和Mg2+至少两种离子的溶液滴加到磷酸钠混合溶液中,滴加离子的总摩尔数与SiO3 2-和PO4 3-的总摩尔数之比为8∶6,滴加完毕后维持溶液温度并连续搅拌陈化0~1000分钟,然后过滤析出的多元微量元素协同掺杂磷酸钙微球,并用去离子水和无水乙醇依次洗涤,然后过滤、真空干燥,备用;1) Add the inorganic salt containing SiO 3 2- and PO 4 3- into the aqueous solution of sodium polyaspartate or sodium polyacrylate at a molar ratio of 1:10, and control the concentration of sodium phosphate to 1-10%. The sodium mixed solution is maintained at 37-60°C, and the pH value of the mixed solution is adjusted to 4.8-7.0, and then a solution containing at least two ions of Ca 2+ , Sr 2+ , Zn 2+ and Mg 2+ is added dropwise to the In the sodium phosphate mixed solution, the ratio of the total number of moles of ions added dropwise to the total number of moles of SiO 3 2- and PO 4 3- is 8:6. After the addition is completed, maintain the temperature of the solution and continue to stir and age for 0 to 1000 minutes , and then filter the precipitated multi-element microelements synergistically doped calcium phosphate microspheres, and wash with deionized water and absolute ethanol in sequence, then filter, vacuum dry, and set aside;
2)按反应产物CaO∶P2O5∶SiO2∶B2O3∶Na2O摩尔之比32~50∶0~12∶40~56∶0~12∶3~8称量适量硝酸钙、磷酸三乙酯、正硅酸乙酯、硼酸和硝酸钠,依次加入乙醇中充分反应,并在60℃下陈化,然后在550~700℃下煅烧,得到生物活性玻璃纳米粉体,称量0.05~0.15g生物活性玻璃纳米颗粒分散到2~6g细胞培养液中制得悬浮液,备用;2) Weigh an appropriate amount of calcium nitrate according to the molar ratio of the reaction product CaO : P2O5 : SiO2 : B2O3 : Na2O : 32-50: 0-12: 40-56: 0-12: 3-8 , triethyl phosphate, ethyl orthosilicate, boric acid and sodium nitrate were added to ethanol in turn to fully react, aged at 60°C, and then calcined at 550-700°C to obtain bioactive glass nanopowder, called Disperse 0.05 to 0.15 g of bioactive glass nanoparticles into 2 to 6 g of cell culture medium to prepare a suspension, and set aside;
3)室温下称量适量海藻酸钠粉末充分搅拌溶解于含500ppm Ca2+和50ppmSr2+的水溶液中,使其成为浓度为5g/L的海藻酸钠水凝胶,备用;3) Weigh an appropriate amount of sodium alginate powder at room temperature, fully stir and dissolve it in an aqueous solution containing 500ppm Ca 2+ and 50ppm Sr 2+ , making it a sodium alginate hydrogel with a concentration of 5g/L, and set aside;
4)室温下称量适量壳聚糖粉末并加入5g/L乙酸溶液中,充分搅拌使其成为浓度为20g/L壳聚糖溶液,备用;4) Weigh an appropriate amount of chitosan powder at room temperature and add it to a 5g/L acetic acid solution, stir it sufficiently to make it a chitosan solution with a concentration of 20g/L, and set aside;
5)称量1~3g按步骤1)制备的多元微量元素协同掺杂磷酸钙微球,并加入到6g按步骤3)制备的海藻酸钠水凝胶中,搅拌均匀后,将步骤4)配制的壳聚糖溶液0.5~1.0g缓慢滴入到该水凝胶中,搅拌均匀,再加入步骤2)制得的悬浮液,搅拌均匀,得到水凝胶-生物活性无机微粒复合物的可注射骨修复材料。5) Weigh 1-3g of multi-element microelements synergistically doped with calcium phosphate microspheres prepared according to step 1), and add them to 6g of sodium alginate hydrogel prepared according to step 3), stir evenly, and then add step 4) Slowly drop 0.5-1.0 g of the prepared chitosan solution into the hydrogel, stir evenly, then add the suspension prepared in step 2), and stir evenly to obtain the hydrogel-biologically active inorganic particle composite. Injection of bone repair material.
本发明中,对掺杂硅、锌、锶和镁活性元素所使用的可溶性无机盐均不存在严格种类限制,一般含Ca2+的无机盐是Ca(CH3COO)2·H2O、Ca(NO3)2和CaCl2中的一种或三者间的任意组合;含PO4 3-的无机盐是Na3PO4、Na2HPO4·2H2O和NaH2PO4·12H2O中的一种或三者间的任意组合;所说的含SiO3 2-的无机盐采用Na2SiO3;含Sr2+无机盐采用SrCl2和Sr(NO3)2中的一种或两者间的任意组合,含Zn2+无机盐采用ZnCl2和Zn(NO3)2中的一种或两者间的任意组合;含Mg2+无机盐采用MgCl2和Mg(NO3)2中的一种或两者间的任意组合。In the present invention, there are no strict restrictions on the types of soluble inorganic salts used for doping silicon, zinc, strontium and magnesium active elements. Generally, the inorganic salts containing Ca 2+ are Ca(CH 3 COO) 2 ·H 2 O, One of Ca(NO 3 ) 2 and CaCl 2 or any combination of the three; the inorganic salts containing PO 4 3- are Na 3 PO 4 , Na 2 HPO 4 ·2H 2 O and NaH 2 PO 4 ·12H 2 O or any combination of the three; the inorganic salt containing SiO 3 2- uses Na 2 SiO 3 ; the inorganic salt containing Sr 2+ uses one of SrCl 2 and Sr(NO 3 ) 2 One or any combination of the two, the inorganic salt containing Zn 2+ adopts one of ZnCl 2 and Zn(NO 3 ) 2 or any combination between the two; the inorganic salt containing Mg 2+ adopts MgCl 2 and Mg(NO 3 ) One of 2 or any combination of the two.
本发明的有益效果在于:The beneficial effects of the present invention are:
本发明的可注射骨修复材料,制作工艺简单,各组分比例经优化设计使其适于微创注射应用,同时良好的流变性使其能适应不同形状的骨折断面和骨缺损空隙充填。按此方法制备的有机-无机复合修复材料不仅具备类似细胞外水凝胶态基质的高含水率凝胶网络,而且含有锶、锌、镁和硅多元微量元素生物活性离子,其凝胶网络内酸碱性由生物活性玻璃溶出的弱碱性离子调节,满足了成骨性细胞迁移、粘附、生长和增殖分化的微环境;其次,高度含水的水凝胶多孔网络结构有利于营养物质传输和新生骨内生长,尤其是由低含量海藻酸钠、壳聚糖组分与多元微量元素协同掺杂磷酸钙多孔性微球、高比表面生物玻璃纳米粒复合形成的复合材料具有快速降解特性,可为骨折快速愈合和新生骨长入提供空间。此外,水凝胶基质网络内海藻酸钠、壳聚糖中阴、阳离子基团对磷酸钙微球和生物玻璃溶出的无机离子产生吸附作用,为细胞内生长提供了最适宜促进细胞增殖、分化的活性离子剂量,从而优化了新骨再生的生物活性。本发明的可生物降解的注射型无机微纳米粒-水凝胶复合物骨修复材料,在骨质疏松症人体内各种骨内微损伤、骨折和骨缺损再生修复中具有广泛应用的前景。The injectable bone repair material of the present invention has a simple manufacturing process, and the ratio of each component is optimized to make it suitable for minimally invasive injection application, and at the same time, its good rheology makes it suitable for different shapes of fracture sections and filling of bone defect spaces. The organic-inorganic composite repair material prepared by this method not only has a high water content gel network similar to the extracellular hydrogel matrix, but also contains multiple trace element bioactive ions of strontium, zinc, magnesium and silicon. The acidity and alkalinity are regulated by the weak alkaline ions leached from the bioactive glass, satisfying the microenvironment for the migration, adhesion, growth, proliferation and differentiation of osteoblast cells; secondly, the highly hydrated hydrogel porous network structure is conducive to the transport of nutrients And the growth of new bone, especially the composite material formed by low content of sodium alginate, chitosan component and multiple trace elements doped calcium phosphate porous microspheres, high specific surface bioglass nanoparticles has rapid degradation characteristics , can provide space for rapid fracture healing and new bone ingrowth. In addition, the sodium alginate, chitosan bardo, and cationic groups in the hydrogel matrix network have adsorption effects on calcium phosphate microspheres and inorganic ions dissolved from bioglass, providing the most suitable environment for intracellular growth to promote cell proliferation and differentiation. Active ion dosage, thus optimizing the biological activity of new bone regeneration. The biodegradable injection-type inorganic micro-nano particle-hydrogel composite bone repair material of the present invention has the prospect of wide application in the regeneration and repair of various intraosseous micro-injuries, fractures and bone defects in osteoporosis human body.
附图说明 Description of drawings
图1为本发明的多元微量元素协同掺杂磷酸钙X射线衍射图谱,图中(a)为含Mg,Zn,Sr和Si微量元素的材料,陈化10分钟;(b)为含Mg,Zn和Sr微量元素的材料,陈化240分钟;(c)为含Mg和Zn微量元素材料的材料,陈化360分钟;(d)为含Mg和Zn微量元素材料的材料,陈化1000分钟。Fig. 1 is multivariate trace element cooperative doping calcium phosphate X-ray diffraction pattern of the present invention, among the figure (a) is the material containing Mg, Zn, Sr and Si trace element, aging 10 minutes; (b) is containing Mg, Materials containing trace elements of Zn and Sr, aged for 240 minutes; (c) materials containing trace elements of Mg and Zn, aged for 360 minutes; (d) materials containing trace elements of Mg and Zn, aged for 1000 minutes .
图2为本发明的多元微量元素协同掺杂磷酸钙扫描电镜照片,图中(a)为含Mg,Zn,Sr和Si微量元素的材料,陈化10分钟;(b)为含Mg,Zn和Sr微量元素的材料,陈化240分钟;(c)为含Mg和Zn微量元素材料的材料,陈化360分钟。Fig. 2 is the scanning electron micrograph of the synergistic doping calcium phosphate calcium phosphate of multivariate trace element of the present invention, among the figure (a) is the material containing Mg, Zn, Sr and Si trace element, aging 10 minutes; (b) is containing Mg, Zn and Sr trace element material, aged for 240 minutes; (c) is a material containing Mg and Zn trace element material, aged for 360 minutes.
图3为复合材料的扫描电镜照片,图中(a)为含Mg,Zn,Sr和Si掺杂微球的复合材料照片;(b)为含Mg,Zn和Sr掺杂微球的复合材料照片;(c)为含Mg,Zn,和Sr掺杂微球的复合材料照片。Fig. 3 is the scanning electron micrograph of composite material, among the figure (a) is the composite material photo containing Mg, Zn, Sr and Si doped microsphere; (b) is the composite material containing Mg, Zn and Sr doped microsphere Photo; (c) is a composite photo containing Mg, Zn, and Sr doped microspheres.
图4为复合材料注射到大鼠股骨骨髓腔模型的X光照片。Fig. 4 is an X-ray photo of the composite material injected into the rat femoral bone marrow cavity model.
图5为复合材料注射到大鼠股骨骨髓腔模型的骨密度测试图。Fig. 5 is a bone density test diagram of the composite material injected into the rat femoral bone marrow cavity model.
图6为复合材料注射到大鼠股骨骨髓腔模型的二维和三维micro-CT照片。Figure 6 is the two-dimensional and three-dimensional micro-CT photos of the composite material injected into the rat femoral bone marrow cavity model.
图7为复合材料注射到大鼠股骨骨髓腔模型的组织标本HE染色光学照片。Fig. 7 is the HE staining optical photograph of the tissue specimen injected with the composite material into the rat femoral bone marrow cavity model.
具体实施方式 Detailed ways
下面结合实例进一步阐明本发明,但这些实例并不限制本发明的范围,凡基于本发明上述内容实现的技术和制备的材料均属于本发明的保护范围。实施例所使用试剂纯度均不低于分析纯试剂纯度指标。The present invention is further illustrated below in conjunction with examples, but these examples do not limit the scope of the present invention, and all technologies and materials prepared based on the above contents of the present invention all belong to the protection scope of the present invention. The purity of reagents used in the examples is not lower than the purity index of analytical reagents.
实施例1Example 1
1)将含SiO3 2-、PO4 3-的Na2SiO3和Na3PO4的无机盐按摩尔比为1∶10加入聚天门冬氨酸钠水溶液中,控制磷酸钠浓度为10%,将此混合溶液维持在37℃,并在连续条件下用盐酸调节溶液的pH值为7.0,连续搅拌形成均匀溶液,再将含Ca2+、Sr2+、Zn2+和Mg2+离子的Ca(CH3COO)2·H2O、SrCl2、ZnCl2和MgCl2溶液滴加到磷酸钠混合溶液中,Ca2+、Sr2+、Zn2+和Mg2+总摩尔数与SiO3 2-和PO4 3-的总摩尔数之比为8∶6,滴加完毕后维持溶液温度并连续搅拌陈化10分钟,然后停止搅拌并过滤析出多元微量元素协同掺杂磷酸钙微球,并用去离子水和无水乙醇依次洗涤3次,然后过滤、真空干燥,X射线衍射图谱和扫描电镜照片分别如图1(a)和图2(a)所示,合成的微量元素掺杂磷酸钙为磷酸八钙微球。1) Add the inorganic salt of Na 2 SiO 3 and Na 3 PO 4 containing SiO 3 2- , PO 4 3- to the aqueous solution of sodium polyaspartate at a molar ratio of 1:10, and control the concentration of sodium phosphate to 10% , keep the mixed solution at 37°C, and adjust the pH value of the solution to 7.0 with hydrochloric acid under continuous conditions, and form a uniform solution with continuous stirring, then add Ca 2+ , Sr 2+ , Zn 2+ and Mg 2+ ions The solution of Ca(CH 3 COO) 2 ·H 2 O, SrCl 2 , ZnCl 2 and MgCl 2 was added dropwise to the mixed solution of sodium phosphate, the total moles of Ca 2+ , Sr 2+ , Zn 2+ and Mg 2+ The total molar ratio of SiO 3 2- and PO 4 3- is 8:6. After the dropwise addition, maintain the solution temperature and continue to stir and age for 10 minutes. The balls were washed three times with deionized water and absolute ethanol, then filtered and dried in vacuum. Heterocalcium phosphate is octacalcium phosphate microspheres.
2)按反应产物CaO∶P2O5∶SiO2∶B2O3∶Na2O摩尔之比36∶4∶52∶4∶4称量适量硝酸钙、磷酸三乙酯、正硅酸乙酯、硼酸和硝酸钠,依次加入搅拌中的乙醇中反应2小时,然后在60℃下陈化24小时,再在700℃下煅烧1.5小时,得到生物活性玻璃纳米粉体,将0.15g生物活性玻璃纳米粉体分散到2g细胞培养液DMEM中制得悬浮液,备用;2) According to the reaction product CaO:P 2 O 5 :SiO 2 :B 2 O 3 :Na 2 O molar ratio 36:4:52:4:4, weigh appropriate amount of calcium nitrate, triethyl phosphate, ethyl orthosilicate Ester, boric acid and sodium nitrate were sequentially added into stirring ethanol for 2 hours, then aged at 60°C for 24 hours, and then calcined at 700°C for 1.5 hours to obtain bioactive glass nanopowder, and 0.15g of bioactive The glass nano-powder is dispersed in 2 g of cell culture medium DMEM to prepare a suspension, which is set aside;
3)室温下称量适量海藻酸钠粉末充分搅拌溶解于含500ppm Ca2+和50ppmSr2+的水溶液中,使其成为浓度为50g/L的水凝胶;3) Weigh an appropriate amount of sodium alginate powder at room temperature and fully stir and dissolve it in an aqueous solution containing 500ppm Ca 2+ and 50ppm Sr 2+ , making it a hydrogel with a concentration of 50g/L;
4)室温下称量适量壳聚糖粉末并加入5g/L乙酸溶液中,充分搅拌使其成为浓度为20g/L壳聚糖溶液,备用;4) Weigh an appropriate amount of chitosan powder at room temperature and add it to a 5g/L acetic acid solution, stir it sufficiently to make it a chitosan solution with a concentration of 20g/L, and set aside;
5)称量3g步骤1)制备的多元微量元素协同掺杂磷酸钙微球,并加入6g步骤3)制备的海藻酸钠水凝胶中,充分搅拌均匀后,将步骤4)配制的壳聚糖溶液1.0g缓慢滴入到该水凝胶中,搅拌均匀;再加入步骤2)制得的悬浮液,搅拌均匀,得到水凝胶-生物活性无机微粒复合物可注射材料。测得复合材料的pH值为7.6,本例制备的复合材料的断面结构形貌扫描电镜照片如图3(a)所示,微球颗粒均匀分布于水凝胶网络内。5) Weigh 3g of multivariate trace elements prepared in step 1) to synergistically dope calcium phosphate microspheres, and add 6g of sodium alginate hydrogel prepared in step 3), and after fully stirring, mix the chitosan prepared in step 4) Slowly drop 1.0 g of the sugar solution into the hydrogel and stir evenly; then add the suspension prepared in step 2) and stir evenly to obtain the hydrogel-bioactive inorganic particle composite injectable material. The pH value of the composite material was measured to be 7.6. The SEM photo of the cross-sectional structure of the composite material prepared in this example is shown in Figure 3(a), and the microsphere particles are evenly distributed in the hydrogel network.
实施例2Example 2
制备方法同实施例1,区别在于:步骤1)将含PO4 3-的Na2HPO4·2H2O无机盐按摩尔比为1∶10加入聚丙稀酸钠水溶液中,控制磷酸钠浓度为10%,将此混合溶液维持在60℃,并在连续条件下用盐酸调节溶液的pH值为4.8,连续搅拌形成均匀溶液,再将含Ca2+、Sr2+、Zn2+和Mg2+离子的CaCl2、SrCl2、ZnCl2和MgCl2溶液滴加到磷酸钠混合溶液中,Ca2+、Sr2+、Zn2+和Mg2+总摩尔数与PO4 3-的摩尔数之比为8∶6,滴加完毕后维持溶液温度并连续搅拌陈化240分钟,磷酸八钙微球颗粒发生部分转化,得到降解速率更缓慢的羟基磷灰石与磷酸八钙复合微球,用去离子水和无水乙醇依次洗涤3次,然后过滤、真空干燥。微球颗粒X射线衍射图谱和形貌扫描电镜照片分别如图1(b)和图2(b)所示。The preparation method is the same as that in Example 1, the difference is that: step 1) adding the Na 2 HPO 4 ·2H 2 O inorganic salt containing PO 4 3- into the aqueous solution of sodium polyacrylate at a molar ratio of 1:10, and controlling the concentration of sodium phosphate to 10%, the mixed solution was maintained at 60°C, and the pH value of the solution was adjusted to 4.8 with hydrochloric acid under continuous conditions, and a uniform solution was formed by continuous stirring, and then Ca 2+ , Sr 2+ , Zn 2+ and Mg 2 + ions of CaCl 2 , SrCl 2 , ZnCl 2 and MgCl 2 are added dropwise to the sodium phosphate mixed solution, the total moles of Ca 2+ , Sr 2+ , Zn 2+ and Mg 2+ and the moles of PO 4 3- The ratio was 8:6. After the dropwise addition, the temperature of the solution was maintained and the solution was continuously stirred and aged for 240 minutes. The octacalcium phosphate microsphere particles were partially transformed, and the composite microspheres of hydroxyapatite and octacalcium phosphate with a slower degradation rate were obtained. Wash with deionized water and absolute ethanol three times successively, then filter and dry in vacuum. The X-ray diffraction patterns and morphology scanning electron micrographs of the microsphere particles are shown in Fig. 1(b) and Fig. 2(b) respectively.
本例制备的复合材料形貌照片如图3(b)所示,微球均匀分布于水凝胶网络内。The morphology photo of the composite material prepared in this example is shown in Figure 3(b), and the microspheres are evenly distributed in the hydrogel network.
实施例3Example 3
制备方法同实施例1,区别在于:步骤1)将含PO4 3-的Na3PO4按摩尔比为1∶10加入聚丙稀酸钠水溶液中,控制磷酸钠浓度为10%,将此混合溶液维持在40℃,并在连续条件下用盐酸调节溶液的pH值为6.8,连续搅拌形成均匀溶液,再将含Ca2+、Zn2+和Mg2+离子的CaCl2、Zn(NO3)2和MgCl2溶液滴加到磷酸钠混合溶液中,Ca2+、Zn2+和Mg2+总摩尔数与PO4 3-的摩尔数之比为8∶6,滴加完毕后维持溶液温度并连续搅拌陈化360分钟,磷酸八钙微球颗粒发生转化,得到降解速率更缓慢的羟基磷灰石微球,用去离子水和无水乙醇依次洗涤3次,然后过滤、真空干燥。微球颗粒X射线衍射图谱和形貌扫描电镜照片分别如图1(c)和图2(c)所示。The preparation method is the same as in Example 1, the difference is that: Step 1) Add Na 3 PO 4 containing PO 4 3- in a molar ratio of 1:10 into the aqueous solution of sodium polyacrylate, control the concentration of sodium phosphate to 10%, and mix the The solution is maintained at 40°C, and the pH value of the solution is adjusted to 6.8 with hydrochloric acid under continuous conditions, and a uniform solution is formed by continuous stirring, and then CaCl 2 , Zn(NO3) containing Ca 2+ , Zn 2+ and Mg 2+ ions 2 and MgCl 2 solution are added dropwise to the sodium phosphate mixed solution, the ratio of the total moles of Ca 2+ , Zn 2+ and Mg 2+ to the moles of PO 4 3- is 8:6, and the temperature of the solution is maintained after the addition is completed. And continuously stirred and aged for 360 minutes, the octacalcium phosphate microsphere particles were transformed, and the hydroxyapatite microspheres with a slower degradation rate were obtained, which were washed three times with deionized water and absolute ethanol, then filtered, and vacuum-dried. The X-ray diffraction patterns and morphology scanning electron micrographs of the microsphere particles are shown in Figure 1(c) and Figure 2(c), respectively.
本例制备的复合材料形貌照片如图3(c)所示,微球均匀分布于水凝胶网络内。The morphology photo of the composite material prepared in this example is shown in Figure 3(c), and the microspheres are evenly distributed in the hydrogel network.
实施例4Example 4
同实施例1制备方法,区别在于:With
步骤1)中陈化时间控制为1000分钟,制得多元微量元素协同掺杂羟基磷灰石微球,微球颗粒X射线衍射图谱如图1(d)所示;The aging time in step 1) is controlled to be 1000 minutes, and multivariate trace elements are synergistically doped with hydroxyapatite microspheres, and the X-ray diffraction pattern of the microsphere particles is shown in Figure 1(d);
步骤2)按反应产物CaO∶P2O5∶SiO2∶B2O3∶Na2O摩尔之比38∶6∶52∶0∶4称量适量硝酸钙、磷酸三乙酯、正硅酸乙酯和硝酸钠,依次加入搅拌中的乙醇中反应2小时,然后在60℃下陈化48小时,再在600℃下煅烧1.5小时,得到生物活性玻璃纳米粉体,将0.10g生物活性玻璃纳米粉体分散到2g细胞培养液DMEM中制得悬浮液;Step 2) Weigh the appropriate amount of calcium nitrate, triethyl phosphate, orthosilicic acid according to the reaction product CaO:P 2 O 5 :SiO 2 : B 2 O 3 :Na 2 O molar ratio 38:6:52:0:4 Ethyl ester and sodium nitrate were sequentially added to ethanol under stirring to react for 2 hours, then aged at 60°C for 48 hours, and then calcined at 600°C for 1.5 hours to obtain bioactive glass nanopowder, and 0.10 g of bioactive glass The nanopowder is dispersed into 2g of cell culture medium DMEM to prepare a suspension;
然后,称量3g按步骤1)制备的微球,并加入6g步骤3)制备的海藻酸钠水凝胶中,充分搅拌均匀后,将步骤4)配制的壳聚糖溶液1.0g缓慢滴入到该水凝胶中,充分搅拌均匀;再将步骤2)制备的悬浮液加入到复合水凝胶中,搅拌均匀,得到水凝胶-生物活性无机微粒复合物材料。测得复合材料的pH值为7.2。Then, weigh 3g of microspheres prepared by step 1), and add 6g of the sodium alginate hydrogel prepared in step 3), after fully stirring, slowly drop 1.0g of chitosan solution prepared in step 4) into the hydrogel, fully stirred evenly; then add the suspension prepared in step 2) into the composite hydrogel, and stir evenly to obtain the hydrogel-biologically active inorganic particle composite material. The pH value of the composite material was measured to be 7.2.
实施例5Example 5
应用实施例1制备的复合材料进行骨质疏松症大鼠股骨骨髓腔骨再生效率和材料降解性测试,具体方法和结果如下:对样品进行γ射线辐射灭菌,对30只12周龄SD雌性大鼠,其中15只摘除卵巢,为OVXed实验组;其余15只仅在卵巢出摘除少量脂肪组织,为Sham假手术对照组。待30只大鼠正常清洁饲养到24周龄时,活体测试实验组和对照组股骨骨密度分别为为0.11±0.03和0.19±0.02,并具有统计学显著性差异,表明实验组大鼠已经患骨质疏松症。再通过γ射线辐射对材料样品进行灭菌,在无菌和麻醉条件下向两组大鼠两后腿股骨腔分别注射无菌样品1.5g,然后骨蜡封进样针孔,缝合皮层。继续饲养1~8周后,按注射过量麻醉剂方法处死大鼠,取完整股骨,分别进行X光、骨密度、micro-CT二维和三维切片结构重建和组织学HE染色表征,分别如图4~7所示。实验组股骨内第8周时发现注射材料新骨矿化(见图4);实验组股骨骨密度随时间快速上升,第8周时与对照组无显著性差异(见图5);尽管实验组多孔骨退化明显,但是注射材料发生矿化明显,对照组材料因快速降解而没有矿化成骨(见图6);组织染色证实第4周开始出现矿化骨,第8周矿化显著,微球颗粒材料降解解体仍存在残余碎片,对照组8后材料降解,没有新骨(见图7)。The composite material prepared in Example 1 was used to test the bone regeneration efficiency and material degradability of the femoral marrow cavity of rats with osteoporosis. The specific methods and results were as follows: the samples were sterilized by γ-ray radiation, and 30 12-week-old SD females were sterilized. Among them, 15 rats had their ovaries removed, which was the OVXed experimental group; the remaining 15 rats had only a small amount of adipose tissue removed from the ovaries, and they were the Sham sham operation control group. When 30 rats were kept clean and kept until 24 weeks old, the bone mineral density of the femur in the experimental group and the control group were 0.11±0.03 and 0.19±0.02 respectively, and there was a statistically significant difference, indicating that the rats in the experimental group had suffered from osteoporosis. The material samples were sterilized by γ-ray radiation, and 1.5 g of sterile samples were injected into the femoral cavities of the two hind legs of the two groups of rats under aseptic and anesthesia conditions, and then the injection needle holes were sealed with bone wax, and the cortex was sutured. After continuing to feed for 1 to 8 weeks, the rats were sacrificed according to the method of overdose anesthesia injection, and the complete femur was taken for X-ray, bone density, micro-CT two-dimensional and three-dimensional slice structure reconstruction and histological HE staining, respectively, as shown in Figure 4 ~7 shown. New bone mineralization was found in the femur of the experimental group at the 8th week (see Figure 4); the bone density of the femur in the experimental group increased rapidly with time, and there was no significant difference from the control group at the 8th week (see Figure 5); although the experimental group The porous bone degeneration was obvious in the group, but the mineralization of the injected material was obvious, and the material in the control group did not mineralize into bone due to rapid degradation (see Figure 6). There are still residual fragments in the degradation and disintegration of the microsphere particle material, and the material is degraded after 8 days in the control group, and there is no new bone (see Figure 7).
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910152789 CN101695584B (en) | 2009-10-15 | 2009-10-15 | Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910152789 CN101695584B (en) | 2009-10-15 | 2009-10-15 | Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101695584A true CN101695584A (en) | 2010-04-21 |
CN101695584B CN101695584B (en) | 2013-04-24 |
Family
ID=42140735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910152789 Expired - Fee Related CN101695584B (en) | 2009-10-15 | 2009-10-15 | Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101695584B (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011072399A1 (en) * | 2009-12-18 | 2011-06-23 | The Governing Council Of The University Of Toronto | Injectable polymer composition for use as a cell delivery vehicle |
CN102432694A (en) * | 2011-09-28 | 2012-05-02 | 郭宏昌 | Medicine for promoting bone cell growth |
CN103068416A (en) * | 2010-06-25 | 2013-04-24 | 阿伯丁大学理事会 | Bone graft system |
CN103446624A (en) * | 2013-07-05 | 2013-12-18 | 华南理工大学 | Preparation method of drug bearing microsphere/chitosan/sodium alginate injectable aquogel |
CN103520764A (en) * | 2013-10-29 | 2014-01-22 | 成都迪康中科生物医学材料有限公司 | Functional dressing, and preparation method and application thereof |
CN104644455A (en) * | 2015-01-26 | 2015-05-27 | 华南理工大学 | Bioglass-sodium alginate composite biomaterial, kit and application |
CN106075587A (en) * | 2016-06-07 | 2016-11-09 | 山东明德生物医学工程有限公司 | Polynary codope bone cement and preparation method |
CN106237379A (en) * | 2016-08-29 | 2016-12-21 | 董晓 | A kind of chlorella bioid modification size controlled activity glass raw powder's production technology |
CN106421929A (en) * | 2016-09-22 | 2017-02-22 | 四川大学 | Injectable calcium phosphate/natural polymer composite material and preparation method and application thereof |
CN106806943A (en) * | 2016-03-31 | 2017-06-09 | 中国科学院上海硅酸盐研究所 | Formed in situ Injectable bio-active composite aquogel and its preparation method and application |
WO2017137005A1 (en) * | 2016-02-13 | 2017-08-17 | Tuan Weihsing | Bioresorbable synthetic bone graft |
CN107050524A (en) * | 2016-12-23 | 2017-08-18 | 江南大学 | A kind of preparation method of novel antibacterial composite biological material |
CN107115562A (en) * | 2017-04-11 | 2017-09-01 | 上海交通大学 | A kind of injection aquagel and its preparation and application for myocardial repair |
WO2017198970A1 (en) * | 2016-05-19 | 2017-11-23 | Universite Claude Bernard Lyon I | Product and process for the preparation of an injectable composition based on chitosan and bioglasses, intended for the regeneration of bone tissue |
CN107721407A (en) * | 2016-08-10 | 2018-02-23 | 中国科学院上海硅酸盐研究所 | A kind of novel bioactive ceramics bracket based on nutrient Sr P Si and its production and use |
CN109260523A (en) * | 2018-09-14 | 2019-01-25 | 广州润虹医药科技股份有限公司 | A kind of calcium phosphate bone cement complex microsphere and its preparation method and application |
CN109331223A (en) * | 2018-09-25 | 2019-02-15 | 广州润虹医药科技股份有限公司 | A kind of drug-loaded biological activity glass complex calcium phosphate bone cement and its application |
CN109395171A (en) * | 2018-11-29 | 2019-03-01 | 广州润虹医药科技股份有限公司 | A kind of bone renovating material of carrying medicament and preparation method thereof |
WO2020044028A1 (en) * | 2018-08-28 | 2020-03-05 | The University Of Sheffield | Solid suspension |
CN112174152A (en) * | 2020-10-21 | 2021-01-05 | 苏州鼎安科技有限公司 | Multi-ion co-doped tetracalcium phosphate powder, and synthesis method and application thereof |
CN113599574A (en) * | 2021-07-28 | 2021-11-05 | 苏州大学 | Regeneration material for muscle repair and preparation method thereof |
CN113633821A (en) * | 2021-08-18 | 2021-11-12 | 上海交通大学医学院附属第九人民医院 | Temperature-sensitive injectable collagen/chitosan/zinc-doped biological glass nanoparticle hydrogel material and preparation method thereof |
CN113929448A (en) * | 2021-11-29 | 2022-01-14 | 西华师范大学 | Gradient structure calcium phosphate particle and preparation method and preparation device thereof |
CN113952512A (en) * | 2021-10-04 | 2022-01-21 | 重庆工商大学 | Composite porous gel microsphere and preparation method and application thereof |
CN114763415A (en) * | 2021-01-14 | 2022-07-19 | 北京大学第三医院(北京大学第三临床医学院) | High-performance processable hydrogel and preparation method and application thereof |
CN115414527A (en) * | 2022-05-16 | 2022-12-02 | 浙江大学 | Application of bionic bone-like composite scaffold, preparation method and rapid repair of bone defect |
CN116003827A (en) * | 2022-09-19 | 2023-04-25 | 中南大学 | Injectable hydrogel for promoting bone chitosan to complex zinc as well as preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1302822C (en) * | 2002-11-28 | 2007-03-07 | 上海瑞邦生物材料有限公司 | In-situ osteoplastic active calcium phosphate cement and its prepn and application |
CN1302821C (en) * | 2005-08-26 | 2007-03-07 | 清华大学 | Preparation method of calcium orthophosphate bone cement degradable to pore in human body |
CN101376035B (en) * | 2008-10-10 | 2012-11-07 | 浙江大学 | Calcium orthophosphate porous particle material with biological activity as well as preparation method and use thereof |
CN101518659B (en) * | 2009-03-30 | 2012-07-11 | 浙江大学 | A bioactive biomimetic calcium phosphate nanomaterial and its preparation method and application |
-
2009
- 2009-10-15 CN CN 200910152789 patent/CN101695584B/en not_active Expired - Fee Related
Cited By (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011072399A1 (en) * | 2009-12-18 | 2011-06-23 | The Governing Council Of The University Of Toronto | Injectable polymer composition for use as a cell delivery vehicle |
US8980248B2 (en) | 2009-12-18 | 2015-03-17 | The Governing Council Of The University Of Toronto | Injectable polymer composition for use as a cell delivery vehicle |
CN103068416A (en) * | 2010-06-25 | 2013-04-24 | 阿伯丁大学理事会 | Bone graft system |
CN103068416B (en) * | 2010-06-25 | 2016-05-11 | 西拉科斯有限公司 | Bone implant system |
CN102432694A (en) * | 2011-09-28 | 2012-05-02 | 郭宏昌 | Medicine for promoting bone cell growth |
CN103446624B (en) * | 2013-07-05 | 2016-04-13 | 华南理工大学 | The preparation method of medicine carrying microballoons/chitosan/sodium alginate injection aquagel |
CN103446624A (en) * | 2013-07-05 | 2013-12-18 | 华南理工大学 | Preparation method of drug bearing microsphere/chitosan/sodium alginate injectable aquogel |
CN103520764A (en) * | 2013-10-29 | 2014-01-22 | 成都迪康中科生物医学材料有限公司 | Functional dressing, and preparation method and application thereof |
CN103520764B (en) * | 2013-10-29 | 2015-06-03 | 成都迪康中科生物医学材料有限公司 | Functional dressing, and preparation method and application thereof |
CN104644455A (en) * | 2015-01-26 | 2015-05-27 | 华南理工大学 | Bioglass-sodium alginate composite biomaterial, kit and application |
CN104644455B (en) * | 2015-01-26 | 2017-10-27 | 华南理工大学 | A kind of bio-vitric sodium alginate composite biological material and kit and application |
WO2017137005A1 (en) * | 2016-02-13 | 2017-08-17 | Tuan Weihsing | Bioresorbable synthetic bone graft |
CN108697823A (en) * | 2016-02-13 | 2018-10-23 | 段维新 | Solid solution, can be by the bone implant product of bio-absorbable and preparation and method for implantation |
CN106806943B (en) * | 2016-03-31 | 2019-08-16 | 中国科学院上海硅酸盐研究所 | Formed in situ Injectable bio-active composite hydrogel and its preparation method and application |
CN106806943A (en) * | 2016-03-31 | 2017-06-09 | 中国科学院上海硅酸盐研究所 | Formed in situ Injectable bio-active composite aquogel and its preparation method and application |
FR3051371A1 (en) * | 2016-05-19 | 2017-11-24 | Univ Claude Bernard Lyon | PRODUCT AND PROCESS FOR THE PREPARATION OF AN INJECTABLE COMPOSITION BASED ON CHITOSAN AND BIOVERRES FOR THE REGENERATION OF BONE TISSUE |
WO2017198970A1 (en) * | 2016-05-19 | 2017-11-23 | Universite Claude Bernard Lyon I | Product and process for the preparation of an injectable composition based on chitosan and bioglasses, intended for the regeneration of bone tissue |
CN106075587A (en) * | 2016-06-07 | 2016-11-09 | 山东明德生物医学工程有限公司 | Polynary codope bone cement and preparation method |
CN106075587B (en) * | 2016-06-07 | 2019-12-24 | 山东明德生物医学工程有限公司 | Multi-element co-doped bone cement and preparation method thereof |
CN107721407A (en) * | 2016-08-10 | 2018-02-23 | 中国科学院上海硅酸盐研究所 | A kind of novel bioactive ceramics bracket based on nutrient Sr P Si and its production and use |
CN107721407B (en) * | 2016-08-10 | 2020-09-18 | 中国科学院上海硅酸盐研究所 | Novel bioactive ceramic scaffold based on nutrient element Sr-P-Si and preparation method and application thereof |
CN106237379A (en) * | 2016-08-29 | 2016-12-21 | 董晓 | A kind of chlorella bioid modification size controlled activity glass raw powder's production technology |
CN106421929A (en) * | 2016-09-22 | 2017-02-22 | 四川大学 | Injectable calcium phosphate/natural polymer composite material and preparation method and application thereof |
CN106421929B (en) * | 2016-09-22 | 2019-11-15 | 四川大学 | A kind of injectable calcium phosphate/natural polymer composite material and its preparation method and application |
CN107050524A (en) * | 2016-12-23 | 2017-08-18 | 江南大学 | A kind of preparation method of novel antibacterial composite biological material |
CN107115562A (en) * | 2017-04-11 | 2017-09-01 | 上海交通大学 | A kind of injection aquagel and its preparation and application for myocardial repair |
US20210244848A1 (en) * | 2018-08-28 | 2021-08-12 | The University Of Sheffield | Solid suspension |
WO2020044028A1 (en) * | 2018-08-28 | 2020-03-05 | The University Of Sheffield | Solid suspension |
CN109260523A (en) * | 2018-09-14 | 2019-01-25 | 广州润虹医药科技股份有限公司 | A kind of calcium phosphate bone cement complex microsphere and its preparation method and application |
CN109331223A (en) * | 2018-09-25 | 2019-02-15 | 广州润虹医药科技股份有限公司 | A kind of drug-loaded biological activity glass complex calcium phosphate bone cement and its application |
CN109331223B (en) * | 2018-09-25 | 2021-07-30 | 广州润虹医药科技股份有限公司 | Medicine-carrying bioactive glass composite calcium phosphate bone cement and application thereof |
CN109395171A (en) * | 2018-11-29 | 2019-03-01 | 广州润虹医药科技股份有限公司 | A kind of bone renovating material of carrying medicament and preparation method thereof |
CN112174152A (en) * | 2020-10-21 | 2021-01-05 | 苏州鼎安科技有限公司 | Multi-ion co-doped tetracalcium phosphate powder, and synthesis method and application thereof |
CN112174152B (en) * | 2020-10-21 | 2023-07-14 | 苏州鼎安科技有限公司 | Polyion co-doped tetracalcium phosphate powder, synthesis method and application |
CN114763415A (en) * | 2021-01-14 | 2022-07-19 | 北京大学第三医院(北京大学第三临床医学院) | High-performance processable hydrogel and preparation method and application thereof |
CN113599574A (en) * | 2021-07-28 | 2021-11-05 | 苏州大学 | Regeneration material for muscle repair and preparation method thereof |
CN113633821A (en) * | 2021-08-18 | 2021-11-12 | 上海交通大学医学院附属第九人民医院 | Temperature-sensitive injectable collagen/chitosan/zinc-doped biological glass nanoparticle hydrogel material and preparation method thereof |
CN113952512A (en) * | 2021-10-04 | 2022-01-21 | 重庆工商大学 | Composite porous gel microsphere and preparation method and application thereof |
CN113929448A (en) * | 2021-11-29 | 2022-01-14 | 西华师范大学 | Gradient structure calcium phosphate particle and preparation method and preparation device thereof |
CN115414527A (en) * | 2022-05-16 | 2022-12-02 | 浙江大学 | Application of bionic bone-like composite scaffold, preparation method and rapid repair of bone defect |
CN116003827A (en) * | 2022-09-19 | 2023-04-25 | 中南大学 | Injectable hydrogel for promoting bone chitosan to complex zinc as well as preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101695584B (en) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695584A (en) | Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof | |
CN104436295B (en) | Strontium-containing calcium silicate bioceramic and preparation method thereof | |
CN100536936C (en) | A kind of inorganic bone graft material, its preparation method and application | |
CN102438667B (en) | Gallium Calcium phosphate biomaterials | |
CN101376035B (en) | Calcium orthophosphate porous particle material with biological activity as well as preparation method and use thereof | |
CN104030718B (en) | Porous calcium carbonate ceramic of a kind of trace elements that adulterates and its preparation method and application | |
CN1323986C (en) | Method for preparing CaO-P2O5-MgO glass reinforced porous beta-tricalcium phosphate bioceramics | |
CN104056305B (en) | A kind of calcium orthophosphate base is combined self-curing bone renovating material and preparation method thereof | |
Qiu et al. | Silicate-doped hydroxyapatite and its promotive effect on bone mineralization | |
CN104288830B (en) | A kind of micro-nano bar-shaped bioactivity glass and preparation method and application | |
CN103272279B (en) | A kind of bioactive multilayer composite ceramic microsphere material, preparation method and application | |
CN101157045A (en) | Bioactive calcium phosphate/tricalcium silicate composite self-curing material, method and application | |
Bavya Devi et al. | Magnesium silicate bioceramics for bone regeneration: a review | |
CN100496625C (en) | Calcium sulfate semihydrate group combined self-curing bio-active material, preparation and application thereof | |
Karasu et al. | Bioactive glasses | |
CN100406072C (en) | Bioactive tricalcium silicate/calcium sulfate hemihydrate composite self-curing material, preparation and application | |
CN108658102A (en) | A kind of raw materials of magnesium oxide and preparation method thereof improving magnesium phosphate cement biocompatibility | |
CN101428153A (en) | Bioactive calcium hydrogen phosphate/tricalcium silicate composite self-curing material and its preparation method and application | |
CN111773432A (en) | Magnesium-based amorphous-calcium phosphate/calcium silicate composite filler and its preparation and application | |
Miao et al. | Multi-stage controllable degradation of strontium-doped calcium sulfate hemihydrate-tricalcium phosphate microsphere composite as a substitute for osteoporotic bone defect repairing: degradation behavior and bone response | |
CN103979945B (en) | A kind of preparation method of bioactive wollastonite ceramics | |
CN100591365C (en) | Inorganic resorbable bone substitute material | |
CN103263691A (en) | High-biological activity composite material for promoting bone regeneration repair and preparation method thereof | |
CN102430147B (en) | Biodegradable strontium-doped calcium sulfate material having biological activity, and its preparation method and use | |
CN101791427B (en) | Alkaline-excited nano silicon dioxide self-curing material with biological activity and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130424 Termination date: 20151015 |
|
EXPY | Termination of patent right or utility model |